Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eurobio Scientific SA

ALERS
Current price
25.75 EUR -0.05 EUR (-0.19%)
Last closed 25.8 EUR
ISIN FR0013240934
Sector Healthcare
Industry Medical Devices
Exchange Euronext Paris
Capitalization 260 691 146 EUR
Yield for 12 month +58.75 %
1Y
3Y
5Y
10Y
15Y
ALERS
21.11.2021 - 28.11.2021

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France. Address: 7 avenue de Scandinavie, Les Ulis, France, 91940

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

28.37 EUR

P/E ratio

41.5323

Dividend Yield

Current Year

+131 007 536 EUR

Last Year

+153 786 198 EUR

Current Quarter

+74 020 573 EUR

Last Quarter

+71 824 736 EUR

Current Year

+53 735 027 EUR

Last Year

+65 545 589 EUR

Current Quarter

+33 607 696 EUR

Last Quarter

+30 905 980 EUR

Key Figures ALERS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 20 784 370 EUR
Operating Margin TTM 9.3 %
PE Ratio 41.5323
Return On Assets TTM 2.57 %
PEG Ratio
Return On Equity TTM 3.75 %
Wall Street Target Price 28.37 EUR
Revenue TTM 145 845 318 EUR
Book Value 17.97 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 23.7 %
Dividend Yield
Gross Profit TTM 100 176 128 EUR
Earnings per share 0.62 EUR
Diluted Eps TTM 0.62 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 89.9 %
Profit Margin 4.59 %

Dividend Analytics ALERS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALERS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 01.09.2017
Dividend Date

Stock Valuation ALERS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 41.5323
Forward PE 9.0498
Enterprise Value Revenue 1.8357
Price Sales TTM 1.7874
Enterprise Value EBITDA 9.1114
Price Book MRQ 1.4438

Financials ALERS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALERS

For 52 weeks

13.91 EUR 26.15 EUR
50 Day MA 25.59 EUR
Shares Short Prior Month
200 Day MA 19.14 EUR
Short Ratio
Shares Short
Short Percent